Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Academic Journal

The American Journal on Addictions

2 Papers Indexed in Blossom

Published Papers

Paywallindividual

Mania following use of ibogaine: A case series

This case report (n=3) examines patients who developed manic symptoms and diagnosed with Bipolar-I disorder in response to ibogaine use. None of the patients had a prior diagnosis or family history of bipolar disorder, but all of them were poly-drug users or recovering from addiction. Manic symptoms which often included grand delusions that lasted up to two weeks after using ibogaine.

Published
April 1, 2015
Journal
The American Journal on Addictions
Authors
Koek, R. J., Kopelowicz, A., Marta, C. J., Ryan, W. C.
Open Accessindividual

Treatment of acute opioid withdrawal with ibogaine

In a case series of 33 open‑label, non‑medical treatments for opioid detoxification, ibogaine resolved signs of acute opioid withdrawal without further drug‑seeking within 24 hours in 25 patients (sustained for 72 hours), with varied outcomes in the remainder and one possible fatality; the authors conclude that ibogaine’s apparent effectiveness warrants systematic clinical investigation.

Published
February 18, 2010
Journal
The American Journal on Addictions
Authors
Alper, K. R., Bastiaans, J., Frenken, G. M. N., Lotsof, H. S., Luciano, D. J.

Quick Facts

Papers Indexed
2
Publisher
Wiley
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.